Agios Pharmaceuticals, Inc.
AGIONasdaqCIK 1439222HealthcareFiscal year ends Dec 31
All transactions: 4
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-22 | Gheuens SarahChief Medical Officer, Officer | Sale | 500 | $37.52 | $18.8k | Form 4 |
| 2026-10-22 | Gheuens SarahChief Medical Officer, Officer | Option exercise | 500 | $25.01 | $12.5k | Form 4 |
| 2026-10-21 | Gheuens SarahChief Medical Officer, Officer | Sale | 1,489 | $37.53 | $55.9k | Form 4 |
| 2026-10-21 | Gheuens SarahChief Medical Officer, Officer | Option exercise | 1,489 | $25.01 | $37.2k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 16:12 ET. Listed shows no prices and gives no investment advice.